FDA Drug Approval and the Ethics of Desperation

JAMA Intern Med. 2021 Dec 1;181(12):1555-1556. doi: 10.1001/jamainternmed.2021.6045.
No abstract available

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Approval / organization & administration*
  • Humans
  • United States
  • United States Food and Drug Administration / ethics*

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab